Celgene (CELG) Price to Free Cash Flow Ratio

Historical price to free cash flow ratio values for Celgene (CELG) over the last 10 years.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $82.794B $11.229B
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.